REPLIMUNE GROUP, INC. (REPL)
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)
Upexi Added to the Russell Microcap® Index
Xunlei Announces US$20 Million Share Repurchase Program
Black Rock Coffee Bar Expands Footprint in Austin with Georgetown Location
Everlert, Inc. (OTC: EVLI), Operating as American Gold & Copper Inc., Signs Memorandum of Understanding for Proposed Acquisition of the Rimrock Copper-Gold Project in Nevada
Cineverse Reports Fourth Quarter and Fiscal Year 2026 Results
Locafy Reports 31% Revenue Growth for the First Nine Months of Fiscal 2026
Abacus Global Management’s Defamation Suit Against Coventry and its Chairman Alan Buerger Advances in U.S. District Court
Marqeta to Announce Second Quarter 2026 Results on August 4, 2026